Arnab Chakravarti MD

Arnab Chakravarti MD
ChairCollege of
080B James Cancer Hosp & Res Inst 300 W 10th Avenue Columbus Ohio 43210
  • Experimental Therapeutics

Current Publications

  • Baiocchi RAGenetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma.Cancer Res 74 1752-65 3/15/2014
  • Chakravarti AEditorial on "targeting Wee1 for the treatment of pediatric high-grade gliomas".Neuro Oncol 16 325 3/1/2014
  • Mehta MPA randomized trial of bevacizumab for newly diagnosed glioblastoma.N Engl J Med 370 699-708 2/20/2014
  • Schackert GIs there pseudoprogression in secondary glioblastomas?Int J Radiat Oncol Biol Phys 87 1094-9 12/1/2013
  • Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi ME, Jaeckle KA, Armstrong TS, Wefel JS, Won M, Blumenthal DT, Mahajan A, Schultz CJ, Erridge S, Baumert B, Hopkins KI, Tzuk-Shina T, Brown PD, Chakravarti A, Curran WJ Jr, Mehta MPDose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.J Clin Oncol 31 4085-91 11/10/2013
  • Ru P, Williams TM, Chakravarti A, Guo DTumor metabolism of malignant gliomas.Cancers (Basel) 5 1469-84 11/8/2013
  • Lautenschlaeger T, Perry J, Peereboom D, Li B, Ibrahim A, Huebner A, Meng W, White J, Chakravarti AIn vitro study of combined cilengitide and radiation treatment in breast cancer cell lines.Radiat Oncol 8 246 10/23/2013
  • Chettiar SN, Cooley JV, Park IH, Bhasin D, Chakravarti A, Li PK, Li C, Jacob NKDesign, synthesis and biological studies of survivin dimerization modulators that prolong mitotic cycle.Bioorg Med Chem Lett 23(19) 5429-33 10/1/2013
  • Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce C, Chakravarti A, Victor J, Lautenschlaeger TMicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.Clin Cancer Res 19(19) 5423-33 10/1/2013
  • Chakravarti A, Bhargava RLymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin.Int J Pediatr Otorhinolaryngol 77(8) 1367-9 8/1/2013
  • Guo D, Bell EH, Mischel P, Chakravarti ATargeting SREBP-1-driven Lipid Metabolism to Treat Cancer.Curr Pharm Des in press 6/25/2013
  • Lautenschlaeger T, George A, Klimowicz AC, Efstathiou JA, Wu CL, Sandler H, Shipley WU, Tester WJ, Hagan MP, Magliocco AM, Chakravarti ABladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival.Oncologist 18(6) 685-6 6/1/2013
  • Carbone DP, Chakravarti AFrom the guest editors: management of locally advanced lung cancer.Cancer J 19(3) 199 5/1/2013
  • Guo D, Bell EH, Chakravarti ALipid metabolism emerges as a promising target for malignant glioma therapy.CNS Oncol 2(3) 289-299 5/1/2013
  • Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta MRTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.Int J Radiat Oncol Biol Phys 85(5) 1206-11 4/1/2013
  • Lawrence YR, Vikram B, Dignam JJ, Chakravarti A, Machtay M, Freidlin B, Takebe N, Curran WJ Jr, Bentzen SM, Okunieff P, Coleman CN, Dicker APNCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.J Natl Cancer Inst 105(1) 11-24 1/2/2013
  • Jacob NK, Cooley JV, Yee TN, Jacob J, Alder H, Wickramasinghe P, Maclean KH, Chakravarti AIdentification of sensitive serum microRNA biomarkers for radiation biodosimetry.PLoS One 8(2) e57603 1/1/2013
  • Meng W, McElroy JP, Volinia S, Palatini J, Warner S, Ayers LW, Palanichamy K, Chakravarti A, Lautenschlaeger TComparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues.PLoS One 8(5) e64393 1/1/2013
  • Waters JD, Sanchez C, Sahin A, Futalan D, Gonda DD, Scheer JK, Akers J, Palanichamy K, Waterman P, Chakravarti A, Weissleder R, Morse B, Marsh N, Furfine E, Chen CC, Carvajal I, Carter BSCT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy.J Neurooncol 110(1) 37-48 10/1/2012
  • Kroonen J, Artesi M, Capraro V, Nguyen-Khac MT, Willems M, Chakravarti A, Bours V, Robe PACasein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells.Int J Oncol 41(2) 776-82 8/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: